Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease

By afschroeder • April 15, 2026

Morrisroe K, Tashkin D, Baron M. Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease. Arthritis Res Ther. 2026 Apr 14;28(1):88. doi: 10.1186/s13075-026-03803-z. PMID: 41981638.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Scalable generation of hematopoietic stem cell-engineered off-the-shelf mono-specific cytotoxic T cells targeting solid tumors

Zhu Y, Yu J, Kim YJ, Tian Y, Li Z, Chen Y, Lyu Z, Zhu E, Zhao AS, Ma N, Zhang C, Kramer A, Wilson[...]

Timing of Parenteral Nutrition in Neonates, Infants, and Children: Current Evidence, Circadian Considerations, and Emerging Directions

Chan AP, Lai RW, Calkins KL. Timing of Parenteral Nutrition in Neonates, Infants, and Children: Current Evidence, Circadian Considerations, and Emerging Directions. Nutrients. 2026 Aug[...]

Safety-Net FoodRx: Repeat Attendance and Produce Consumption Patterns in a Produce Distribution Program

Ferguson F, Baham M, McCarthy WJ, Brown AF, Casillas A, Vassar S, Moon G, Caldwell JI, Darwish-Elsherbiny F, Shah D, Kuo T. Safety-Net FoodRx: Repeat[...]